Table 3.
Laboratory data including plasma B-type natriuretic peptide (BNP).
| LVR(+), n = 24 | LVR(-), n = 73 | P* | |
|---|---|---|---|
| BNP1 (day 2) (pg/ml) | 342.1 ± 369.5 | 322.0 ± 440.2 | 0.841 |
| BNP2 (day 7) (pg/ml) | 327.8 ± 256.1 | 224.7 ± 305.7 | 0.148 |
| BNP3 (day 90) (pg/ml) | 208.1 ± 263.7 | 82.4 ± 153.7 | 0.039 |
| BNP4 (day 180) (pg/ml) | 200.2 ± 335.1 | 76.6 ± 155.3 | 0.124 |
| ∆BNP12 (pg/ml) | -8.9 ± 248.0 | 90.3 ± 248.7 | 0.099 |
| RBNP12 (%) | -40.5 ± 109.6 | -14.7 ± 179.5 | 0.518 |
| ∆BNP13 (pg/ml) | 110.8 ± 324.3 | 246.7 ± 376.9 | 0.125 |
| RBNP13 (%) | 14.4 ± 92.2 | 69.4 ± 25.9 | <0.001 |
| ∆BNP14 (pg/ml) | 103.9 ± 298.3 | 253.6 ± 420.4 | 0.141 |
| RBNP14 (%) | 18.3 ± 103.2 | 69.3 ± 38.9 | 0.042 |
| Uric acid (mg/dl) | 9.2 ± 15.0 | 6.0 ± 1.4 | 0.296 |
| Peak CK-MB (ng/ml) | 158.8 ± 156.0 | 75.8 ± 98.6 | 0.023 |
| Peak Troponin I (ng/ml) | 12.7 ± 24.5 | 7.1 ± 19.8 | 0.258 |
| hs-CRP (mg/L) | 37.5 ± 44.2 | 33.3 ± 36.2 | 0.662 |
| hs-CRP (6th month) (mg/L) | 4.5 ± 12.3 | 3.9 ± 7.0 | 0.782 |
∆BNP12= BNP1-BNP2: one week BNP decrease difference;
RBNP12=(BNP1-BNP2) x 100/BNP1(%): one week BNP decrease ratio
∆BNP13= BNP1-BNP3: 3-month BNP decrease difference;
RBNP13= (BNP1-BNP3) x 100/BNP1(%): 3-month BNP decrease ratio;
∆BNP14= BNP1-BNP4: 6-month BNP decrease difference;
RBNP14= (BNP1-BNP4) x 100/BNP1(%): 6-month BNP decrease ratio;
CK-MB: creatine kinase-MB; hs-CRP: high-sensitivity C-reactive protein
*P < 0.05 was considered statistically significant.